Abstract: The present invention relates to compositions and methods for reducing or eliminating wrinkles and improving skin texture and appearance. The compositions, which comprise at least one acetyl hexapeptide and a dipeptide that is optionally complexed to an amino acid, may be administered orally, sublingually, topically and/or transdermally.

Abstract: Topical formulations comprising a dipeptide having a sequence of Lys-Pro, optionally complexed with an amino add, and at least one bioflavonoid or bioflavonoid extract in a cosmetically or pharmaceutically acceptable carrier provide intense skin hydration and improve skin texture and appearance.

Abstract: Provided are pharmaceutical compositions for skin lightening, which are particularly useful in treating skin hyperpigmentation, together with methods for their use. The compositions comprise glutathione conjugated to a peptide having a sequence comprising PKEK (SEQ ID NO: 1) and cysteamine or a pharmaceutical salt thereof.

Abstract: Provided are pharmaceutical compositions for skin lightening, which are particularly useful in treating skin hyperpigmentation, together with methods for their use. The compositions comprise a peptide having a sequence comprising PKEK, alpha arbutin and/or sutilains.

Abstract: Topical formulations comprising a dipeptide having a sequence of Lys-Pro, optionally complexed with an amino acid, and at least one bioflavonoid or bioflavonoid extract in a cosmetically or pharmaceutically acceptable carrier provide intense skin hydration and improve skin texture and appearance.

Abstract: The present invention relates to compositions and methods for reducing or eliminating wrinkles and improving skin texture and appearance. The compositions, which comprise at least one acetyl hexapeptide and a dipeptide that is optionally complexed to an amino acid, may be administered orally, sublingually, topically and/or transdermally.

Abstract: Provided are pharmaceutical compositions for skin lightening, which are particularly useful in treating skin hyperpigmentation, together with methods for their use. The compositions comprise glutathione conjugated to a peptide having a sequence comprising PKEK and cysteamine or a pharmaceutical salt thereof.

Abstract: Compositions and methods disclosed herein may be used for treating or preventing viral infections. The compositions may be administered orally to subjects in need of preventative or therapeutic treatment and/or the compositions may be used to disinfect surfaces in order to prevent or limit the spread of disease through surface contact.

Abstract: Growth hormone releasing factor (GHRF) analogs that can be used to induce endogenous growth hormone secretion are disclosed, as well as pharmaceutical compositions comprising the GHRF analogs and methods of using the GHRF analogs.

Abstract: Growth hormone releasing factor (GHRF) analogs that can be used to induce endogenous growth hormone secretion are disclosed; as well as pharmaceutical compositions comprising the GHRF analogs and methods of using the GHRF analogs.

Abstract: A number of peptides of from 28 to 44 amino acids, including therein a sequence of L-K-E-K-K (SEQ ID NO: 1) have a physiological activity that can be wound healing activity, immunostimulant activity, or growth factor activity. The peptides can be linear or circular, and if linear, the amino terminus can be optionally acetylated. The invention also includes nucleic acids encoding these peptides, vectors incorporating these nucleic acid sequences, and host cells transfected with these vectors, as well as methods for producing these peptides by culturing these host cells and purifying these peptides. The invention further includes pharmaceutical compositions and methods for using these peptides.

Abstract: A number of peptides of from 28 to 44 amino acids, including therein a sequence of L-K-E-K-K (SEQ ID NO: 1) have a physiological activity that can be wound healing activity, immunostimulant activity, or growth factor activity. The peptides can be linear or circular, and if linear, the amino terminus can be optionally acetylated. The invention also includes nucleic acids encoding these peptides, vectors incorporating these nucleic acid sequences, and host cells transfected with these vectors, as well as methods for producing these peptides by culturing these host cells and purifying these peptides. The invention further includes pharmaceutical compositions and methods for using these peptides.

Abstract: A number of peptides of from 28 to 44 amino acids, including therein a sequence of L-K-E-K-K (SEQ ID NO: 1), have a physiological activity that can be wound healing activity, immunostimulant activity, or growth factor activity. The peptides can be linear or circular, and, if linear, its amino terminus can be optionally acetylated. The invention also includes nucleic acids encoding these peptides, vectors incorporating these nucleic acid sequences, and host cells transfected with these vectors, as well as methods for producing these peptides by culturing these host cells and purifying the peptides. The invention further includes pharmaceutical compositions and methods for using these peptides.

Abstract: A number of peptides of from 28 to 44 amino acids, including therein a sequence of L-K-E-K-K (SEQ ID NO: 1) have a physiological activity that can be wound healing activity, immunostimulant activity, or growth factor activity. The peptides can be linear or circular, and if linear, the amino terminus can be optionally acetylated. The invention also includes nucleic acids encoding these peptides, vectors incorporating these nucleic acid sequences, and host cells transfected with these vectors, as well as methods for producing these peptides by culturing these host cells and purifying these peptides. The invention further includes pharmaceutical compositions and methods for using these peptides.

Abstract: A number of peptides of from 28 to 44 amino acids, including therein a sequence of L-K-E-K-K (SEQ ID NO: 1), have a physiological activity that can be wound healing activity, immunostimulant activity, or growth factor activity. The peptides can be linear or circular, and, if linear, its amino terminus can be optionally acetylated. The invention also includes nucleic acids encoding these peptides, vectors incorporating these nucleic acid sequences, and host cells transfected with these vectors, as well as methods for producing these peptides by culturing these host cells and purifying the peptides. The invention further includes pharmaceutical compositions and methods for using these peptides.

Abstract: The invention is a dermatological healing kit having a pigment stabilizer component, and an antiinflammatory emollient component, and these components each by themselves, wherein the pigment stabilizer contains a mixture of glycerine, butylene glycol, bearberry extract, and mitracarpe extract; magnesium ascorbyl phosphate; and tricholoma matsutake singer; and the antiinflammatory emollient component contains xanthoxylum bungeanum planch; decarboxy camosine chlorhydrate; polygonum multiforum thumb; rubus thunbergii hance.cum spp.; and an aqueous mixture of siegerbecka orientals extract.